ORLANDO, Fla. – AdventHealth is conducting a clinical trial to test the effectiveness of a COVID-19 vaccine by Janssen Pharmaceuticals.AdventHealth’s Chief Scientific Officer, Dr.
Steven Smith, said the company plans on having up to 60,000 people take part in the study.During a briefing on Thursday, News 6 asked how effective the vaccine will be once it becomes available.[TRENDING: Eta floods Florida | Romaine calm: Florida man arrested after lettuce tirade | DeSantis accused of wanting herd immunity]“This vaccine will have the data to say, ‘Yes, it’s safe and effective' (in the) first quarter (of 2021) and then probably full approval, if everything goes right, somewhere around June,’” Smith said.Pfizer, meanwhile, announced this week that.